T0	ActivePlacebo 1746 1800	The control condition contained many active components
T1	ActivePlacebo 26042 26145	the control variant employed in the current trial represented a smaller ‘dose’ of CBM positive training
T2	Population 26987 27102	the sample recruited was one in which it would have been particularly difficult to detect between-group differences
T3	Control 32772 32813	The absence of another control comparator
T4	Generalization 33719 33777	it is unknown whether the current results would generalize
T5	VerySpecificPopulation 33781 33917	more severe patients not taking part in a research trial or to those with other Axis I or II disorders not assessed in the current study
T6	OutcomeMeasures 33208 33309	We cannot exclude the possibility that symptom reductions reflected the operation of a placebo effect
T7	Population 34226 34252	participant self-selection
